Literature DB >> 31311025

Evaluation of Serum Glucagon-Like Peptide 1 and Vitamin D Levels in Elderly Patients with Bone Fractures.

Özhan Pazarci1, Halef Okan Dogan2, Seyran Kilinc3, Yalkin Çamurcu4.   

Abstract

OBJECTIVES: To evaluate the correlation between levels of serum vitamin D and glucagon-like peptide-1 (GLP-1) in elderly patients with bone fractures.
MATERIALS AND METHODS: This study included 56 patients and 31 control subjects. The patients included were those aged ≥65 years who were admitted to our hospital with a diagnosis of bone fracture. The control group comprised age-matched, healthy individuals. Levels of serum vitamin D and GLP-1 were measured and compared between the 2 groups.
RESULTS: Significant differences were noted between the groups in terms of serum levels of vitamin D (p < 0.001) and serum levels of GLP-1 (p < 0.001). A positive correlation was observed between serum levels of vitamin D and GLP-1.
CONCLUSION: Serum levels of GLP-1 were found to be significantly lower in elderly patients with bone fracture compared to healthy adults. In addition, a significant correlation was found between decreased vitamin D and GLP-1 levels. These results may therefore demonstrate the protective effects of GLP-1 on bone structure and metabolism, similar to those of vitamin D.
© 2019 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Keywords:  Bone; Elderly patients; Fracture; Glucagon-like peptide-1; Vitamin D

Mesh:

Substances:

Year:  2019        PMID: 31311025      PMCID: PMC7315181          DOI: 10.1159/000502132

Source DB:  PubMed          Journal:  Med Princ Pract        ISSN: 1011-7571            Impact factor:   1.927


  27 in total

Review 1.  Ageing and the epidemiology of multimorbidity.

Authors:  Miguel J Divo; Carlos H Martinez; David M Mannino
Journal:  Eur Respir J       Date:  2014-08-19       Impact factor: 16.671

2.  Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline.

Authors:  Michael F Holick; Neil C Binkley; Heike A Bischoff-Ferrari; Catherine M Gordon; David A Hanley; Robert P Heaney; M Hassan Murad; Connie M Weaver
Journal:  J Clin Endocrinol Metab       Date:  2011-06-06       Impact factor: 5.958

Review 3.  What Is the Role of Vitamin D Supplementation in Acute Fracture Patients? A Systematic Review and Meta-Analysis of the Prevalence of Hypovitaminosis D and Supplementation Efficacy.

Authors:  Sheila Sprague; Brad Petrisor; Taryn Scott; Tahira Devji; Mark Phillips; Hayley Spurr; Mohit Bhandari; Gerard P Slobogean
Journal:  J Orthop Trauma       Date:  2016-02       Impact factor: 2.512

Review 4.  Vitamin D and bone.

Authors:  Daniel D Bikle
Journal:  Curr Osteoporos Rep       Date:  2012-06       Impact factor: 5.096

Review 5.  Current concepts of molecular aspects of bone healing.

Authors:  Rozalia Dimitriou; Eleftherios Tsiridis; Peter V Giannoudis
Journal:  Injury       Date:  2005-08-15       Impact factor: 2.586

6.  Exendin-4, a glucagon-like peptide-1 receptor agonist, prevents osteopenia by promoting bone formation and suppressing bone resorption in aged ovariectomized rats.

Authors:  Xue Ma; Jingru Meng; Min Jia; Long Bi; Ying Zhou; Yukun Wang; Jing Hu; Gonghao He; Xiaoxing Luo
Journal:  J Bone Miner Res       Date:  2013-07       Impact factor: 6.741

7.  Vitamin D Insufficiency and Fracture Risk in Urban Children.

Authors:  Rachel M Thompson; Daniel M Dean; Sarah Goldberg; Mary J Kwasny; Craig B Langman; Joseph A Janicki
Journal:  J Pediatr Orthop       Date:  2017-09       Impact factor: 2.324

8.  Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans.

Authors:  C Orskov; L Rabenhøj; A Wettergren; H Kofod; J J Holst
Journal:  Diabetes       Date:  1994-04       Impact factor: 9.461

Review 9.  Gut Hormones and Their Effect on Bone Metabolism. Potential Drug Therapies in Future Osteoporosis Treatment.

Authors:  Sine Paasch Schiellerup; Kirsa Skov-Jeppesen; Johanne Agerlin Windeløv; Maria Saur Svane; Jens Juul Holst; Bolette Hartmann; Mette Marie Rosenkilde
Journal:  Front Endocrinol (Lausanne)       Date:  2019-02-26       Impact factor: 5.555

Review 10.  The Impact of Glucagon-Like Peptide-1 on Bone Metabolism and Its Possible Mechanisms.

Authors:  Chenhe Zhao; Jing Liang; Yinqiu Yang; Mingxiang Yu; Xinhua Qu
Journal:  Front Endocrinol (Lausanne)       Date:  2017-05-03       Impact factor: 5.555

View more
  1 in total

Review 1.  Novel Insights into the Roles and Mechanisms of GLP-1 Receptor Agonists against Aging-Related Diseases.

Authors:  Wei Peng; Rui Zhou; Ze-Fang Sun; Jia-Wei Long; Yong-Qiang Gong
Journal:  Aging Dis       Date:  2022-04-01       Impact factor: 6.745

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.